Cluster1 sources· last seen 1d ago· first seen 1d ago
Takeda signs US$600M AI drug discovery deal with Insilico
Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas. The companies did not disclose which therapeutic areas or disease targets will be covered under the collaboratio
Lead: AI NewsBigness: 4takedasigns600mdrugdiscovery
📡 Coverage
10
1 news source
🟠 Hacker News
0
🔴 Reddit
0
📈 Google Trends
0
Full methodology: How scoring works
Receipts (all sources)
Takeda signs US$600M AI drug discovery deal with Insilico
RSS · AI News · 1d ago
score 108
Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas. The companies did not disclose which therapeutic areas or disease targets will be covered under the collaboratio